PoliticalRepoPoliticalRepo

European Union · Record · QUESTION_WRITTEN_PRIORITY

P-8-2017-003716

Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

openEuropean Union· European Parliament· IT

Introduced

2 June 2017

Last action

—

Status

QUESTION_WRITTEN_PRIORITY

Sponsors

—

Subjects

Discovery layer

Source updated

2 June 2017

Official sourceDownload fileView documentsShare

Official titles

Authentic titles published by the source. The stored canonical title is not replaced.

1 official language

  • English

    Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

Records

Official record P-8-2017-003716 from European Union at European Parliament. Dated 2 June 2017. Status: QUESTION_WRITTEN_PRIORITY.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

11 official files

Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

View fileDownload file

  • Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018

    DownloadOpen at official source

  • Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018

    ViewDownloadOpen at official source

  • Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018

    ViewDownloadOpen at official source

  • Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018

    ViewDownloadOpen at official source

  • Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018

    DownloadOpen at official source

  • Answer

    QUESTION_WRITTEN_ANSWER

    ViewDownloadOpen at official source

  • Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018

    DownloadOpen at official source

  • Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018

    ViewDownloadOpen at official source

  • Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018

    ViewDownloadOpen at official source

  • Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018

    ViewDownloadOpen at official source

  • Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa

    QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018

    DownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.